NCT03541135

Brief Summary

Population aging makes it necessary to identify factors related to unhealthy aging. The purpose of this study is to examine the association between ideal cardiovascular health, diet and other lifestyles and biological risk factors (either clasical or emergent) and the risk of physical and cognitive function impairment and mortality in a cohort of community-living individuals aged 65 years and over.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
4,000

participants targeted

Target at P75+ for all trials

Timeline
53mo left

Started Jan 2016

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress71%
Jan 2016Sep 2030

Study Start

First participant enrolled

January 1, 2016

Completed
2.2 years until next milestone

First Submitted

Initial submission to the registry

March 20, 2018

Completed
2 months until next milestone

First Posted

Study publicly available on registry

May 30, 2018

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2018

Completed
12 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2030

Expected
Last Updated

December 20, 2023

Status Verified

December 1, 2023

Enrollment Period

2.7 years

First QC Date

March 20, 2018

Last Update Submit

December 14, 2023

Conditions

Keywords

Cardiovascular healthDietFunctional limitationsFrailtyOlder Adults

Outcome Measures

Primary Outcomes (23)

  • Functional limitations on bicep-femoral flexibility

    Chair Sit and Reach test

    3 years

  • Functional limitations on shoulder flexibility

    Back Scratch test

    3 years

  • Functional limitations on balance

    Short Physical Performance Battery (SPPB): Balance test

    3 years

  • Functional limitations on gait speed

    Short Physical Performance Battery (SPPB): Gait Speed test

    3 years

  • Functional limitations on strength of legs

    Short Physical Performance Battery (SPPB): Chair Stand test

    3 years

  • Functional limitations on strength of hands

    Hydraulic hand dynamometer (Jamar Plus +)

    3 years

  • Functional limitations on activities of daily living

    Activities of Daily Living (ADLs) test

    3 years

  • Functional limitations on instrumental activities of daily living

    Instrumental Activities of Daily Living (IADLs) test

    3 years

  • Functional limitations on olfactory function

    Pocket Smell test

    3 years

  • Functional limitations on taste function

    NIH Tool Box Taste test

    3 years

  • Functional limitations on auditory function

    Audiometry

    3 years

  • Cognitive impairment

    Mini-Mental State Examination (MMSE)

    3 years

  • Executive function limitations on working memory

    Digits Forward test (WAIS-III),

    3 years

  • Executive function limitations on programmed motor tasks

    Three Hand Position test of Luria

    3 years

  • Executive function limitations on motor response control

    GO-NO-GO test.

    3 years

  • Memory function limitations

    Seven Minute Screen (orientation, memory, clock drawing, verbal fluency)

    3 years

  • Frailty

    Fried criteria

    3 years

  • Falls

    From the question: "How many times have you fallen down since the last interview? a) Number of falls; b) Number of injurious falls; c) Number of falls with fracture

    3 years

  • Arterial stiffness estimated by pulse wave velocity (PWV)

    Ambulatory Blood Pressure Monitor using the oscillometric method (Mobil-O-Graph PWA) to estimate PWV (m/s) over a 24 hours period

    3 years

  • Arterial stiffness estimated by central sistolic blood pressure (CSBP)

    Ambulatory Blood Pressure Monitor using the oscillometric method (Mobil-O-Graph PWA) to estimate CSBP (mmHg) over a 24 hours period

    3 years

  • Arterial stiffness estimated by augmentation index (AI)

    Ambulatory Blood Pressure Monitor using the oscillometric method (Mobil-O-Graph PWA) to estimate AI (%) over a 24 hours period

    3 years

  • 24-h systolic and diastolic blood pressure

    Ambulatory Blood Pressure Monitor using the oscillometric method (Mobil-O-Graph PWA) to estimate brachial blood pressure (systolic and diastolic) (mmHg) over a 24 hours period

    3 years

  • Mortality

    From the National Institute of Statistics of Spain

    3 years

Eligibility Criteria

Age65 Years - 95 Years
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Community-living individuals in the region of Madrid, Spain, aged 65 years or older.

You may qualify if:

  • Non-institutionalized residents in the region of Madrid, Spain.
  • years and over

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Preventive Medicine and Public Health. Universidad Autonoma de Madrid

Madrid, 28029, Spain

Location

Related Publications (2)

  • Marcos-Delgado A, Yevenes-Briones H, Fernandez-Villa T, Martin-Sanchez V, Guallar-Castillon P, Rodriguez-Artalejo F, Lopez-Garcia E. Association between diet quality and malnutrition: pooled results from two population-based studies in older adults. BMC Geriatr. 2024 May 10;24(1):417. doi: 10.1186/s12877-024-04984-5.

  • Vega-Cabello V, Struijk EA, Caballero FF, Lana A, Arias-Fernandez L, Banegas JR, Rodriguez-Artalejo F, Lopez-Garcia E. Dietary Micronutrient Adequacy and Risk of Multimorbidity in Community-dwelling Older Adults. Am J Clin Nutr. 2023 Jul;118(1):34-40. doi: 10.1016/j.ajcnut.2023.05.008. Epub 2023 May 3.

Biospecimen

Retention: SAMPLES WITH DNA

whole blood, urine

MeSH Terms

Conditions

Cognitive DysfunctionFrailty

Condition Hierarchy (Ancestors)

Cognition DisordersNeurocognitive DisordersMental DisordersPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Fernando Rodríguez-Artalejo, MD, PhD

    Department of Preventive Medicine and Public Health. Universidad Autónoma de Madrid

    PRINCIPAL INVESTIGATOR
  • Jose R Banegas, MD, PhD

    Department of Preventive Medicine and Public Health. Universidad Autónoma de Madrid

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Preventive Medicine and Public Health

Study Record Dates

First Submitted

March 20, 2018

First Posted

May 30, 2018

Study Start

January 1, 2016

Primary Completion

September 1, 2018

Study Completion (Estimated)

September 1, 2030

Last Updated

December 20, 2023

Record last verified: 2023-12

Locations